These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7305440)

  • 1. Polymorphonuclear granulocyte chemotaxis and chemotactic factor generation by concanavalin A-stimulated peripheral blood mononuclear cells in patients with psoriasis.
    Csató M; Dobozy A; Hunyadi J; Kenderessy SA; Simon N
    Arch Dermatol Res; 1981; 271(3):259-64. PubMed ID: 7305440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokinetic and chemotactic factors in psoriasis scale extracts.
    Dahl MV; Lindroos WE; Nelson RD
    J Invest Dermatol; 1978 Dec; 71(6):402-6. PubMed ID: 722120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil locomotion and serum chemotactic and chemokinetic activities in pustulosis palmoplantaris compared with psoriasis.
    Lundin A; Håkansson L; Michaëlsson G; Venge P
    Arch Dermatol Res; 1987; 279(6):385-91. PubMed ID: 3674962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the mobilities of granulocytes and the chemotactic factor production by human mononuclear cells (author's transl)].
    Nakayama M
    Hokkaido Igaku Zasshi; 1981 Mar; 56(2):217-31. PubMed ID: 7327510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotactic factor production by rat polymorphonuclear leukocytes: stimulation with opsonized zymosan particles and inhibition by dexamethasone.
    Kurihara A; Ojima F; Tsurufuji S
    Biochem Biophys Res Commun; 1984 Mar; 119(2):720-5. PubMed ID: 6712653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulus-dependent increased generation of oxygen intermediates in monocytes and polymorphonuclear leukocytes in psoriasis.
    Schopf RE; Straussfeld E
    J Invest Dermatol; 1985 Jan; 84(1):73-6. PubMed ID: 3965581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of chemotactic factors in serum and wound fluid by dextranomer.
    Oredsson SU; Gottrup F; Beckmann A; Hohn DC
    Surgery; 1983 Sep; 94(3):453-7. PubMed ID: 6193593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mononuclear cell versus monocyte chemotaxis in psoriasis.
    Tosca A; Hatzis J; Panteleos D; Varelzidis A
    J Dermatol; 1985 Jun; 12(3):226-31. PubMed ID: 3908525
    [No Abstract]   [Full Text] [Related]  

  • 9. Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis--enhancing properties of psoriatic serum.
    Ellis CN; Kang S; Grekin RC; Voorhees JJ; Silva J
    J Am Acad Dermatol; 1985 Sep; 13(3):437-43. PubMed ID: 4056118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphonuclear leukocyte function in psoriasis: chemotaxis, chemokinesis, beta-adrenergic receptors, and proteolytic enzymes of polymorphonuclear leukocytes in the peripheral blood from psoriatic patients.
    Fräki JE; Jakoi L; Davies AO; Lefkowitz RJ; Snyderman R; Lazarus GS
    J Invest Dermatol; 1983 Sep; 81(3):254-7. PubMed ID: 6309987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphonuclear leukocyte random migration and chemotaxis in psoriatic and healthy adult smokers and non-smokers.
    Sonnex TS; Carrington P; Norris P; Greaves MW
    Br J Dermatol; 1988 Nov; 119(5):653-9. PubMed ID: 3207619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulation.
    Preissner WC; Schröder JM; Christophers E
    Br J Dermatol; 1983 Jul; 109(1):1-8. PubMed ID: 6860565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil chemotaxis in psoriasis before and after PUVA therapy.
    Guillot B; Guilhou JJ; Vendrel JP; Meynadier J
    Arch Dermatol Res; 1983; 275(1):19-22. PubMed ID: 6847241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self-activated serum.
    Kawohl G; Szperalski B; Schröder JM; Christophers E
    Br J Dermatol; 1980 Nov; 103(5):527-33. PubMed ID: 7437318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte and neutrophil chemotaxis in psoriasis. Relation to the clinical status and the type of psoriasis.
    Ternowitz T
    J Am Acad Dermatol; 1986 Dec; 15(6):1191-9. PubMed ID: 3027138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Pityrosporum-derived chemoattractant for polymorphonuclear leukocytes of psoriatic patients.
    Bunse T; Mahrle G
    Acta Derm Venereol; 1996 Jan; 76(1):10-2. PubMed ID: 8721481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphonuclear leukocyte function in psoriasis vulgaris.
    Pease CT; Fennell M; Staughton RC; Brewerton DA
    Br J Dermatol; 1987 Aug; 117(2):161-7. PubMed ID: 3651338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in the chemoluminescence behavior of micro- and macrophages in psoriasis: more than just an epiphenomenon?].
    Schopf RE; Straussfeld E; Morsches B
    Z Hautkr; 1985 May; 60(10):797-8, 801-2, 807. PubMed ID: 4013455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphonuclear leukocytes in psoriasis.
    Glinski W; Mansbridge J
    Cutis; 1985 May; 35(5):441-2. PubMed ID: 4006509
    [No Abstract]   [Full Text] [Related]  

  • 20. Normal chemotactic migration of polymorphonuclear leukocytes stimulated with mononuclear-derived chemotactic factor in ulcerative colitis.
    Hermanowicz A; Nawarska Z
    Int Arch Allergy Appl Immunol; 1986; 81(1):63-8. PubMed ID: 3744579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.